Skip to product information
1 of 3

CLEC5A His Tag Protein, Cynomolgus

CLEC5A His Tag Protein, Cynomolgus

Catalog Number: UA016114 Brand: UA BIOSCIENCE
Price:
Regular price $295 USD
Regular price Sale price $295 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Cynomolgus
Synonyms CLECSF5, superfamilymember 5, C-type lectin domain family 5, member A, MDL1, MDL-1, DAP12-associating lectin 1
Accession XP_005551048.3
Amino Acid Sequence

Pro28-Arg188 with His Tag at the C-Terminus

Expression System HEK293
Molecular Weight 40-55kDa (Reducing)
Purity >95% by SDS-PAGE & HPLC
Conjugation Unconjugated
Tag His Tag
Physical Appearance Lyophilized powder
Storage Buffer

PBS, pH7.4, 5% trehalose

Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage

· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.

· 3 months, -20 to -80℃ under sterile conditions after reconstitution.

· 1 week, 2 to 8℃ under sterile conditions after reconstitution.

· Please avoid repeated freeze-thaw cycles.

Reference

1. ZHANG T N, HUANG X M, GOODWIN J E, et al. Endothelial CLEC5A drives barrier dysfunction and vascular leakage responsible for lung injury in bacterial pneumonia and sepsis[J]. Science Advances, 2025, 11(24): eadt7589.
2. HOU L, et al. C-type lectin domain family 5 member A-mediated activation of macrophages via a bispecific antibody enhances anti-HER2 therapy[J]. Journal for ImmunoTherapy of Cancer, 2026, 14(4): e014799.
3. CHEN R, WU W, CHEN S Y, et al. A pan-cancer analysis reveals CLEC5A as a biomarker for cancer immunity and prognosis[J]. Frontiers in Immunology, 2022, 13: 831542.

Background

CLEC5A, also known as C-type lectin domain family 5 member A, is a transmembrane receptor coupled to the adaptor protein DAP12 (DNAX-activating protein of 12 kDa) and belongs to the C-type lectin-like receptor superfamily. Its extracellular region contains a single C-type lectin-like domain (CTLD), which is connected via a transmembrane segment to the ITAM motif of intracellular DAP12, mediating downstream signal transduction. CLEC5A is predominantly expressed on myeloid immune cells, including monocytes/macrophages, dendritic cells, and neutrophils, serving as a critical pattern recognition receptor (PRR) for the recognition of pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Functionally, CLEC5A participates in the regulation of inflammatory responses, macrophage polarization, and the tumor immune microenvironment, playing pivotal roles in sepsis, viral infections, and tumor progression. In recent years, CLEC5A has garnered significant attention as a novel immunotherapeutic target, with bispecific antibodies, antibody-drug conjugates (ADCs), and small-molecule inhibitors actively under development, demonstrating promising clinical application prospects in the treatment of solid tumors such as breast cancer and osteosarcoma, as well as sepsis-associated lung injury.

Picture

SDS-PAGE

2μg (R: reducing condition, N:non-reducing condition).

SEC-HPLC

The purity of CLEC5A His Tag Protein, Cynomolgus is more than 95% determined by SEC-HPLC.

SPR

Galectin-9 Protein, Human (Cat. No. UA010431) immobilized on CM5 Chip can bind CLEC5A His Tag Protein, Cynomolgus (Cat. No. UA016114) with an affinity constant of 1.407 nM as determined in a SPR assay.